|
| 37910594 | Tumor Volume Growth Rates and Doubling Times during Active Surveillance of IDH-mutant Low-Grade Glioma. | Clin Cancer Res | 2024 |
| 36802833 | Efficacy of immunotherapy for melanoma brain metastases in patients with concurrent corticosteroid exposure. | CNS Oncol | 2023 |
| 37671017 | A topic modeling approach reveals the dynamic T cell composition of peripheral blood during cancer immunotherapy. | Cell Rep Methods | 2023 |
| 37962891 | Acupuncture vs Massage for Pain in Patients Living With Advanced Cancer: The IMPACT Randomized Clinical Trial. | JAMA Netw Open | 2023 |
| 37667855 | Integration of peripheral blood- and tissue-based biomarkers of response to immune checkpoint blockade in urothelial carcinoma. | J Pathol | 2023 |
| 37906192 | Outcomes Following Early Postoperative Adjuvant Radiosurgery for Brain Metastases. | JAMA Netw Open | 2023 |
| 37653066 | Addressing racial and ethnic disparities in AACR project GENIE. | NPJ Precis Oncol | 2023 |
| 37540824 | Dyadic communication in rare cancer: a registry-based study of patients with Erdheim-Chester disease and their caregivers. | Blood Adv | 2023 |
| 35798857 | Real-world use of bone modifying agents in metastatic, castration-resistant prostate cancer. | Prostate Cancer Prostatic Dis | 2023 |
| 37317993 | Preclinical and clinical evaluation of Buparlisib (BKM120) in recurrent/refractory Central Nervous System Lymphoma. | Leuk Lymphoma | 2023 |
| 37187218 | COMT Val158Met Affects the Analgesic Response to Acupuncture Among Cancer Survivors With Chronic Pain. | J Pain | 2023 |
| 36989257 | Effect of acupuncture versus usual care on sleep quality in cancer survivors with chronic pain: Secondary analysis of a randomized clinical trial. | Cancer | 2023 |
| 37039320 | Beyond the 5-year milestone: Long-term survivorship of melanoma patients treated off-trial with anti-PD-1. | Pigment Cell Melanoma Res | 2023 |
| 37103999 | Telehealth-Based Music Therapy Versus Cognitive Behavioral Therapy for Anxiety in Cancer Survivors: Rationale and Protocol for a Comparative Effectiveness Trial. | JMIR Res Protoc | 2023 |
| 37400251 | Outcomes after interruption of targeted therapy in patients with histiocytic neoplasms. | Br J Haematol | 2023 |
| 37067886 | Is more better? Increased doses of high dose methotrexate and addition of rituximab is associated with improved outcomes in a large primary CNS lymphoma cohort. | Ann Lymphoma | 2023 |
| 37001503 | T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants. | Cell | 2023 |
| 37223888 | The GENIE BPC NSCLC Cohort: A Real-World Repository Integrating Standardized Clinical and Genomic Data for 1,846 Patients with Non-Small Cell Lung Cancer. | Clin Cancer Res | 2023 |
| 37162890 | Uncovering the hidden structure of dynamic T cell composition in peripheral blood during cancer immunotherapy: a topic modeling approach. | bioRxiv | 2023 |
| 36626408 | Elucidating Analytic Bias Due to Informative Cohort Entry in Cancer Clinico-genomic Datasets. | Cancer Epidemiol Biomarkers Prev | 2023 |
| 36546452 | Patient-reported fatigue and pain in Erdheim-Chester disease: a registry-based, mixed methods study. | Haematologica | 2023 |
| 34597380 | Real-World Use of Bone-Modifying Agents in Metastatic Castration-Sensitive Prostate Cancer. | J Natl Cancer Inst | 2022 |
| 35437688 | Coping with glioblastoma: prognostic communication and prognostic understanding among patients with recurrent glioblastoma, caregivers, and oncologists. | J Neurooncol | 2022 |
| 35766876 | Melanoma-Specific Clinical Outcomes of Inpatient Immune Checkpoint Blockade Treatment. | Oncologist | 2022 |
| 35699501 | A Population-Based Study of Treatment and Survival in Older Glioma Patients. | JNCI Cancer Spectr | 2022 |
| 36581960 | Acupuncture versus massage for pain in patients living with advanced cancer: a protocol for the IMPACT randomised clinical trial. | BMJ Open | 2022 |
| 36106631 | Increased p53 expression induced by APR-246 reprograms tumor-associated macrophages to augment immune checkpoint blockade. | J Clin Invest | 2022 |
| 36037413 | Integrated Multidisciplinary Brain Metastasis Care Reduces Patient Visits and Shortens Time to Adjuvant Irradiation. | JCO Oncol Pract | 2022 |
| 36352503 | Kaposi Sarcoma in the United States: Understanding Disparate Risk. | JNCI Cancer Spectr | 2022 |
| 36265089 | Association Between Remote Monitoring and Acute Care Visits in High-Risk Patients Initiating Intravenous Antineoplastic Therapy. | JCO Oncol Pract | 2022 |
| 36188434 | Challenges and positive impact of rare cancer caregiving: A mixed-methods study of caregivers of patients with Erdheim-Chester disease and other histiocytic neoplasms. | EClinicalMedicine | 2022 |
| 35192403 | A Scalable Quality Assurance Process for Curating Oncology Electronic Health Records: The Project GENIE Biopharma Collaborative Approach. | JCO Clin Cancer Inform | 2022 |
| 35074903 | Ipilimumab alone or in combination with nivolumab in patients with advanced melanoma who have progressed or relapsed on PD-1 blockade: clinical outcomes and translational biomarker analyses. | J Immunother Cancer | 2022 |
| 35128987 | Incidence of Seizure and Associated Risk Factors in Patients in the Medical Intensive Care Unit (ICU) at Memorial Sloan Kettering Cancer Center (MSK) from 2016-2017. | J Intensive Care Med | 2022 |
| 35067410 | Symptoms, Surgical Events, and Length of Stay of Surgical Oncology Outpatients. | J Perianesth Nurs | 2022 |
| 35244701 | Analysis of a Remote Monitoring Program for Symptoms Among Adults With Cancer Receiving Antineoplastic Therapy. | JAMA Netw Open | 2022 |
| 35113288 | Quantitative assessment of circulating tumor cells in cerebrospinal fluid as a clinical tool to predict survival in leptomeningeal metastases. | J Neurooncol | 2022 |
| 35236371 | Rosai-Dorfman-Destombes disease of the nervous system: a systematic literature review. | Orphanet J Rare Dis | 2022 |
| 34928709 | Adaptive Dosing of Nivolumab + Ipilimumab Immunotherapy Based Upon Early, Interim Radiographic Assessment in Advanced Melanoma (The ADAPT-IT Study). | J Clin Oncol | 2022 |
| 34734967 | Implications of Selection Bias Due to Delayed Study Entry in Clinical Genomic Studies. | JAMA Oncol | 2022 |
| 34521610 | Employing competing risks analysis in an aging population where many patients die from other causes. | J Geriatr Oncol | 2022 |
| 33411618 | Apples and Oranges? Considerations for EHR-Based Analyses Aggregating Data From Interventional Clinical Trials and Point-of-Care Encounters in Oncology. | JCO Clin Cancer Inform | 2021 |
| 33651913 | Melanoma brain metastasis presentation, treatment, and outcomes in the age of targeted and immunotherapies. | Cancer | 2021 |
| 33734288 | Effectiveness of Electroacupuncture or Auricular Acupuncture vs Usual Care for Chronic Musculoskeletal Pain Among Cancer Survivors: The PEACE Randomized Clinical Trial. | JAMA Oncol | 2021 |
| 33509808 | Therapeutic Implications of Detecting MAPK-Activating Alterations in Cutaneous and Unknown Primary Melanomas. | Clin Cancer Res | 2021 |
| 33507480 | Characterization of chemotherapy-induced peripheral neuropathy using patient-reported outcomes and quantitative sensory testing. | Breast Cancer Res Treat | 2021 |
| 34433638 | LAG-3 expression on peripheral blood cells identifies patients with poorer outcomes after immune checkpoint blockade. | Sci Transl Med | 2021 |
| 34406564 | Cerebrospinal fluid diversion for leptomeningeal metastasis: palliative, procedural and oncologic outcomes. | J Neurooncol | 2021 |
| 34702752 | Risks and benefits of reinduction ipilimumab/nivolumab in melanoma patients previously treated with ipilimumab/nivolumab. | J Immunother Cancer | 2021 |
| 34396326 | Cancer and Clot: A Deadly Dance. | JACC CardioOncol | 2021 |